BNKL - Bionik Laboratories Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

Bionik Laboratories Corp.

483 Bay Street
Office N105
Toronto, ON M5G 2C9
Canada
416-640-7887
http://www.bioniklabs.com

SectorHealthcare
IndustryMedical Care Facilities
Full Time Employees28

Key Executives

NameTitlePayExercisedYear Born
Dr. Eric Michel Dusseux M.D., MSc, MBACEO & Director668.05kN/A1968
Mr. Michal PrywataCo-Founder, CTO & Director233.44kN/A1991
Ms. Leslie N. MarkowChief Financial Officer252.47kN/A1960
Mr. William HarrisMarketing DirectorN/AN/AN/A
Mr. Loren W. WassChief Commercial OfficerN/AN/A1962
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion ARM that allows clinicians to deliver sensor motor therapy to the shoulder and elbow to develop new neural pathways; InMotion ARM/HAND for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion WRIST, a rehabilitation device that enables clinicians to deliver optimum intensive sensor motor wrist and forearm therapy to patients with neurological conditions. The company is also developing InMotion HOME, an upper extremity product that allows patients to extend their therapy for as long as needed while rehabilitating at home; and ARKE, a robotic lower body exoskeleton designed for wheelchair bound individuals suffering from spinal cord injuries, strokes, and other mobility disabilities. Bionik Laboratories Corp. was founded in 2010 and is headquartered in Toronto, Canada.

Corporate Governance

Bionik Laboratories Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.